NCT06350539 Personalized Models for Cancer Research
| NCT ID | NCT06350539 |
| Status | Recruiting |
| Phase | — |
| Sponsor | New York Stem Cell Foundation Research Institute |
| Condition | Solid Tumor, Adult |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2024-02-15 |
| Primary Completion | 2034-02-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2024-02-15 with a primary completion date of 2034-02-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to accelerate cancer research ranging from disease mechanisms to personalized medicine approaches that will help to realize the promise of precision medicine for oncology.
Eligibility Criteria
Inclusion Criteria: * Adults ages 18 and older with a solid tumor cancer diagnosis. * Adults ages 18 and older serving as healthy controls. Exclusion Criteria: * Human fetuses. * Neonates. * Children. * Wards of the state. * Prisoners.
Contact & Investigator
Laura Andres-Martin, PhD
PRINCIPAL INVESTIGATOR
New York Stem Cell Foundation Research Institute
Frequently Asked Questions
Who can join the NCT06350539 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Solid Tumor, Adult. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06350539 currently recruiting?
Yes, NCT06350539 is actively recruiting participants. Contact the research team at clinicalresearch@nyscf.org for enrollment information.
Where is the NCT06350539 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT06350539 clinical trial?
NCT06350539 is sponsored by New York Stem Cell Foundation Research Institute. The principal investigator is Laura Andres-Martin, PhD at New York Stem Cell Foundation Research Institute. The trial plans to enroll 500 participants.